中国P站

Multilobular tumor; Bone neoplasm; Cranial tumors; Orthopedic oncology; Bone pathology; Lobulated bone lesions; Bone tumor spectrum; Radiologic diagnosis; Surgical management; Histopathology

Introduction

Bone tumors are a heterogeneous group of neoplasms with variable biological behaviors, ranging from benign lesions to highly aggressive malignancies. Among the lesser-known entities within this spectrum are multilobular tumors, notable for their lobular architecture and predilection for flat bones [1]. Often slow-growing and seemingly benign, these tumors may nevertheless exhibit aggressive local behavior, leading to destruction of adjacent tissues and significant clinical morbidity. The characterization and treatment of multilobular tumors demand a thorough understanding of their distinct clinical, radiographic, and histological features. Given the rarity of these tumors in humans and the overlap in presentation with other bone neoplasms, their diagnosis and management present unique challenges that warrant detailed exploration [2].

Description

Multilobular tumors, sometimes referred to in veterinary literature as multilobular osteochondrosarcomas or chondroma-like tumors, are most commonly found in the cranial bones, particularly the skull and occasionally the mandible and pelvis. In humans, they are exceedingly rare but bear clinical significance due to their aggressive yet indolent nature. These tumors typically manifest as firm, immobile masses with a slow but progressive enlargement. Patients may present with localized swelling, neurological symptoms (when the skull is involved), or functional impairment depending on tumor location [3].

Radiographically, multilobular tumors exhibit a characteristic "popcorn" or "soap-bubble" appearance, reflecting their multilobulated structure and internal calcifications. CT and MRI are valuable in delineating the extent of bony and soft tissue involvement, especially in anatomically complex regions like the skull base. Despite their benign histologic appearance, these tumors often infiltrate surrounding bone and soft tissues, blurring the lines between benign and malignant behaviour [4].

Histologically, multilobular tumors are composed of cartilage, bone, and fibrous tissue arranged in lobules separated by fibrous septae. The cellular atypia is usually mild, but the architectural complexity and potential for local invasion necessitate a cautious approach. Immunohistochemical staining and molecular profiling may be employed to differentiate these tumors from other entities such as chondrosarcomas, osteomas, or ossifying fibromas [5].

Surgical resection remains the cornerstone of treatment. Complete excision with negative margins is ideal but often difficult due to the location and extent of the lesion. Incomplete resections are associated with a higher risk of recurrence, underscoring the importance of careful preoperative planning. Reconstruction may be required, particularly when the tumor involves craniofacial bones, and can range from autografts and allografts to custom implants and flaps, depending on the extent of resection [6].

Discussion

The rarity of multilobular tumors contributes to the diagnostic dilemma they often pose. They share radiologic and histologic features with several other bone neoplasms, making definitive diagnosis challenging. This highlights the importance of multidisciplinary tumor boards and specialist input from radiologists, pathologists, and orthopedic oncologists. Early referral and biopsy by experienced teams can minimize misdiagnosis and suboptimal management [7].

Given their infiltrative nature, the treatment philosophy for multilobular tumors aligns more closely with that of low-grade malignant tumors rather than benign lesions. Radical surgical excision with wide margins remains the best chance for durable local control, though this may come at the cost of function and cosmesis, especially in craniofacial locations. In such cases, the role of reconstructive surgery and rehabilitation becomes paramount in optimizing patient outcomes [8].

Adjuvant therapies such as radiation or chemotherapy are not typically employed due to the low mitotic activity of these tumors and lack of proven efficacy. However, in cases where complete excision is not feasible or in recurrent disease, radiation therapy may be considered on a case-by-case basis. Long-term surveillance is essential, given the risk of local recurrence and the occasional potential for pulmonary metastasis, particularly in larger or incompletely excised tumors [9].

The role of novel imaging techniques, including PET scans and diffusion-weighted MRI, is under investigation to better delineate tumor margins and monitor for recurrence. Likewise, advances in molecular diagnostics may eventually offer biomarkers that predict behavior or guide adjuvant treatment. As with many rare tumors, data is limited, and the need for centralized registries and collaborative research is critical to improving our understanding and management of multilobular bone tumors. Veterinary studies have provided valuable insights into the natural history and behavior of these tumors, especially in canine models. While extrapolation to human pathology must be done with caution, these studies underscore the importance of a comparative oncology approach and highlight potential avenues for research [10].

Conclusion

Multilobular tumors occupy a unique and understudied position within the spectrum of bone neoplasms. Their slow-growing yet locally aggressive nature, complex anatomy, and histologic ambiguity make them a clinical challenge. Accurate diagnosis, complete surgical excision, and vigilant follow-up are critical to effective management. As orthopedic oncology continues to evolve, so too must our understanding of rare entities like multilobular tumors. Through multidisciplinary collaboration, improved diagnostic tools, and shared clinical experience, we can better define their role in bone tumor pathology and enhance care for affected patients. Continued research and reporting will be essential in shaping evidence-based guidelines for the diagnosis and management of these intriguing tumors.

References

1. Carthew RW, Sontheimer EJ (2009) . Cell 136: 642-655.

   , ,

2. Li C, Zamore PD (2019) . Cold Spring Harbor Protoc 4: 247-262.

   , , Crossref

3. Liu S, Jaouannet M, Dempsey DMA, Imani J, Coustau C, et al. (2020) . Biotechnol Adv 39: 107463.

   , ,

4. Clancy S (2008) . Nature Education 1: 102.

5. Borges F, Martienssen RA (2015) . Nature Rev Mol Cell Biol 16: 727-741.

   , , Crossref

6. Obbard DJ, Gordon KHJ, Buck AH, Jiggins FM (2009) . Philos Trans R Soc Lond Ser B Biol Sci 364: 99-115.

   , , Crossref

7. Williams M, Clark G, Sathasivan K, Islam AS (2004) . Plant Tissue Culture and Biotechnology 1-18.

8. Agrawal N, Dasaradhi PVN, Mohmmed A, Malhotra P, Bhatnagar RK, et al. (2003) . Microbiol Mol Biol Rev 67: 657-685.

   , , Crossref

9. Chen X, Jiang L, Zheng J, Chen F, Wang T, et al. (2019) . J Exp Bot 70: 3851-3866.

   , ,

10. Wilson RC, Doudna JA (2013) . Annu Rev Biophys 42: 217-239.

    , , Crossref